Literature DB >> 1630580

Dying back type axonal degeneration of sensory nerve terminals in muscle spindles of the gracile axonal dystrophy (GAD) mutant mouse.

K Oda1, K Yamazaki, H Miura, H Shibasaki, T Kikuchi.   

Abstract

A disorder of the gracile axonal dystrophy (GAD) mutant mouse is characterized by a neuromuscular disease with sensory ataxia (detectable 30 days after birth) and paresis of the hindlimbs (detectable at 80 days). In the sensory ataxia stage, histological study of the primary sensory system shows that, in addition to the lesions in the central nervous system, peripherally projecting axons have also started to degenerate at their distal ends in muscle spindles. Although the structure of Ia fibre endings appear normal until 15 days after birth, initial changes in the annulo-spiral structure are detected around the 20th day by a degeneration of the terminal axons. Degeneration then progressed proximally and the secondary endings also start to degenerate. Neuron cell bodies located in the dorsal root ganglia are morphologically intact until the later stages. Chronological studies indicate that, although axonal degeneration progresses throughout life, it is accentuated during the rapid somatic growth period. Around 50 days of age, transient regeneration takes place at axonal endings when somatic growth has attained a plateau. Such primary sensory endings tend to be restored by fine, multiple axons which gain access to the intrafusal fibres through the original endoneurial tubes. Ultrastructural observations at the fully affected stage show intrafusal muscle fibres lying scattered within spindles due to loss of the fine network of inner capsule layers and an almost complete loss of sensory endings from the surface of intrafusal muscle fibres. These results indicate that this mutant mouse is a useful model for naturally occurring 'dying back' type axonal degeneration or 'central and peripheral distal axonopathies', and would provide significant information about the complete evolution of the pathological processes involved.

Entities:  

Mesh:

Year:  1992        PMID: 1630580     DOI: 10.1111/j.1365-2990.1992.tb00789.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  7 in total

1.  Fine structural changes of muscle spindles in the gracile axonal dystrophy mutant mouse.

Authors:  A Takagi; K Oda; T Kikuchi; H Kajihara
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

Review 2.  Pathological proteins in Parkinson's disease: focus on the proteasome.

Authors:  Heather Snyder; Benjamin Wolozin
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

3.  Differential transport and local translation of cytoskeletal, injury-response, and neurodegeneration protein mRNAs in axons.

Authors:  Dianna Willis; Ka Wan Li; Jun-Qi Zheng; Jay H Chang; August B Smit; August Smit; Theresa Kelly; Tanuja T Merianda; James Sylvester; Jan van Minnen; Jeffery L Twiss
Journal:  J Neurosci       Date:  2005-01-26       Impact factor: 6.167

4.  A new mouse model for infantile neuroaxonal dystrophy, inad mouse, maps to mouse chromosome 1.

Authors:  Yoshibumi Matsushima; Tateki Kikuchi; Hisae Kikuchi; Nobutsune Ichihara; Akira Ishikawa; Yasushi Ishijima; Masayoshi Tachibana
Journal:  Mamm Genome       Date:  2005-02       Impact factor: 2.957

5.  Mammalian E4 is required for cardiac development and maintenance of the nervous system.

Authors:  Chie Kaneko-Oshikawa; Tadashi Nakagawa; Mitsunori Yamada; Hiroo Yoshikawa; Masaki Matsumoto; Masayoshi Yada; Shigetsugu Hatakeyama; Keiko Nakayama; Keiichi I Nakayama
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

6.  Linkage mapping of alpha-2 adrenergic receptor genes to mouse chromosomes 2 and 5.

Authors:  R E Link; B K Kobilka; G S Barsh
Journal:  Mamm Genome       Date:  1993-11       Impact factor: 2.957

Review 7.  Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction.

Authors:  Paul Bishop; Dan Rocca; Jeremy M Henley
Journal:  Biochem J       Date:  2016-08-15       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.